Feng Jiang

23PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Nov 06, 2026
Discordant Primary Tumor and Nodal Response After Neoadjuvant Chemoimmunotherapy Identifies an Adverse Postoperative Subgroup in Esophageal Squamous Cell Carcinoma.

|Aug 13, 2026
AI-driven dual-task prediction model for co-stratifying efficacy and toxicity in NSCLC immunotherapy.

|Jan 14, 2026
Integration of habitat radiomics and traditional radiomic features for predicting pathological complete response in esophageal squamous cell carcinoma following neoadjuvant immunotherapy and chemotherapy: a multicenter comparative study.

Zhiyun Xu, Yijiang Lu, Fengyi Zuo

|Dec 20, 2025
Suppressing the OTUD7A/KDM5B/GABPA axis enhances the sensitivity of cisplatin through inducing ferroptosis in KRAS-mutant LUAD.

Rujia Si, Ziyang Shen, Ying Sui

|Nov 10, 2025
The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer.

Yuxian Qian, Hui Wang, Yipeng Feng

|Oct 10, 2025
ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancer.

Shaodi Wen, Xiaoyue Du, Miaolin Zhu

Pageof 4

Frequent Collaborators

9 joint publications

Gaochao Dong

6 joint publications

Lin Xu

5 joint publications

Hui Wang

2 joint publications

Yingkuang Liang